Dr. Otis Brawley Named to Agilent Board of Directors

Leading authority on cancer research joins Agilent board SANTA CLARA, Calif. -- Agilent Technologies, Inc. (NYSE: A) today announced that Dr. Otis W. Brawley, a Bloomberg Distinguished Professor with the Department of Oncology and Epidemiology at the Johns Hopkins University School of Medicine, has been elected to Agilent’s board of directors, effective Nov. 17, 2021. [...]

Sartorius Opens Cell Culture Technology Center in the Scientific Hub of Ulm, Germany

Ulm, Germany -- The life science group Sartorius officially opened its Cell Culture Technology Center at Science Park III, a major hub for cutting–edge research and scientific discovery near many of Germany’s top universities. Around 120 employees work at this Sartorius facility featuring special laboratories and covering 6,000 square meters, some 65,000 square feet, to develop cell lines [...]

LabMinds Announces an Oversubscribed Funding Round Of $6.4M

BOSTON -- LabMinds Inc., an award-winning lab automation robotics company, announced it closed a $6.4M funding round in the third quarter. The funding round was completed by the company’s major investors including Waters Corporation and Red Deer Capital. This round also included funding from new investors. The funding will be used to drive commercialization of [...]

WattIQ Announces Partnership with My Green Lab to Provide Scientific Community with Asset Intelligence Data

Insight will help the scientific community accelerate their path to achieving zero carbon emissions by 2050 SAN FRANCISCO -- WattIQ, an enterprise-grade, cloud-based asset intelligence platform, is pleased to announce that it has entered into a partnership with My Green Lab, the world's leading nonprofit organization dedicated to improving the sustainability of scientific research, to provide insight into [...]

Leinco Technologies Receives Growth Equity Investment From Ampersand Capital Partners

ST. LOUIS, Mo. -- Leinco Technologies, a specialty manufacturer of life science reagents used in drug discovery research and in vitro diagnostics applications, today announced a majority recapitalization of the company by Ampersand Capital Partners, a private equity firm specializing in growth equity investments in the life sciences and healthcare sectors. Ampersand's investment will be used to [...]

Illumina and Sequoia Capital China Select First Startups to join Genomics Incubator in China

First-of-its-kind Incubator will support companies poised to deliver breakthrough applications in genomics and multiomics SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN), and Sequoia Capital China, a leading investment firm, today jointly announced the selection of the first two startup companies joining the Sequoia Capital China Intelligent Healthcare Genomics Incubator, Powered by Illumina. Located in Zhangjiang [...]

Jumpcode Genomics Names Brandon Poe Chief Financial Officer

Seasoned finance and life sciences executive, Brandon Poe, joins rapidly growing team, supporting company growth SAN DIEGO, CA – Jumpcode Genomics, a genome technology platform company focused on improving the understanding of human biology, announced today that Brandon Poe has joined as Chief Financial Officer. Poe brings 25 years of financial experience in the life sciences, [...]

Rebeca Sanchez Sarmiento joins Insightful Science and Dotmatics as Chief Financial Officer

Appointment brings extensive financial industry experience to drive global growth and build corporate value of newly combined organization that is aiming to make the world a healthier, cleaner and better place to live San Diego, CA and Bishop’s Stortford, UK, 17 November 2021 —Insightful Science, the world's most widely adopted software platform for scientific R&D and [...]

ZEISS Celebrates 175 Years of Innovation, Passion and the Courage to Develop

ZEISS ran a virtual celebration to mark its 175th anniversary at its founding site in Jena. German Federal President Frank-Walter Steinmeier said: "Its interplay of entrepreneurial spirit, drive to research, and inventiveness make the ZEISS Group a pioneer of modern industry." After a 5-million-euro donation to the Deutsches Museum, the global initiative "A Heart for [...]

HTG and Icahn School of Medicine at Mount Sinai Announce Bladder Cancer Research Collaboration

HTG’s Innovative Transcriptome Panel Technology to be Leveraged in Retrospective Studies TUCSON, Ariz. -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, and the Icahn School of Medicine at Mount Sinai (Icahn Mount Sinai), world-renowned for its groundbreaking research, announced they have entered into [...]

Access IBO on Knowledge Center